Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Nov 27 2020

Recombinant Cytokines

  • Snapshot
    • A 56-year-old man presents to his primary care physician due to shortness of breath and fatigue. He reports that these symptoms have progressively worsened over the course of a few weeks. Medical history is significant for type II diabetes mellitus and chronic kidney disease with his last eGFR reading at 82 mL/min/1.73 m2. He has yet to need dialysis. Laboratory testing is significant for a hemaglobin of 9.5 g/dL and an eGFR of 55 mL/min/1.73 m2. After further evaluation of non-renal causes of anemia it was determined that erythropoietin should be added to his treatment regimen to improve his symptoms.
  • Introduction
      • Immunosuppressants
      • Medication
      • Mechanism of Action
      • Clinical Use
      • Aldesleukin
      • IL-2 product which leads to
        • T-, B-cell, and NK cells
          • proliferation
          • differentiation
          • recruitment
      • Metastatic renal cell carcinoma
      • Metastatic melanoma
      • Erythropoietin (epoetin alfa)
      • Stimulates erythroid progenitor cells to
        • divide and differentiate
      • Anemia
      • Sargramostim
      • Granulocyte colony stimulating factors to result in neutrophil
        • proliferation
        • differentiation
        • activation
      • To recover
        • white count and bone marrow
      • IFN-α
      • Multiple effects
      • Chronic hepatitis B and C
      • Malignant melanoma
      • Condyloma acuminatum
      • Hairy cell leukemia
      • Kaposi sarcoma
      • IFN-β
      • Multiple effects
      • Multiple sclerosis
      • IFN-γ
      • Multiple effects
      • Chronic granulomatous disease
      • Romiplostim (thrombopoietin)
      • A thrombopoietin (TPO) analog that acts on the TPO receptor to
        • ↑ platelet count
      • Thrombocytopenia
      • Eltrombopag
      • A TPO agonist that leads to
        • ↑ platelet count
      • Thrombocytopenia
      • Oprelvekin (IL-11)
      • A thrombopoietic growth factor that results in
        • ↑ platelet count
      • Thrombocytopenia
Card
1 of 0
Question
1 of 1
Private Note